Clinical trial
Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes…
NCT00142545 · Mylan Bertek Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00142545 |
|---|---|
| Title | Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease |
| Official title | Long-Term Safety and Effectiveness of Subcutaneous Injections of Apomorphine in the Treatment of "Off" Episodes in Patients With "On-Off" or "Wearing-Off" Effects Associated With Late-Stage Parkinson's Disease |
| Lead sponsor | Mylan Bertek Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | apomorphine HCl injection |
| Enrollment | 800 |
| Start date | Jul 1, 1999 |
| Completion | Jul 1, 2005 |
| First posted | Sep 2, 2005 |
| Last update posted | Sep 2, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: